Concepedia

Publication | Open Access

Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results

DOIFull Paper Access

112

Citations

44

References

2023

Year

Kelly C. Goldsmith, Julie R. Park, Kimberly Kayser, Jemily Malvar, Yueh‐Yun Chi, Susan Groshen, Judith G. Villablanca, Kateryna Krytska, Lillian M. Lai, Patricia T. Acharya,
Nature Medicine

References

YearCitations

Page 1